CA-based Aizon secures $20million in series C round funding. With participation from current investors Atlantic Bridge, Crosslink Capital, and Uncork Capital, NewVale Capital led the round.

With the money, the company hopes to improve customer service and expedite its development pipeline. Under the direction of CEO Pep Gubau, Amazon uses artificial intelligence, sophisticated predictive analytics, and other smart factory technologies to give pharmaceutical firms an accessible GMP AI platform.

With Aizon, clients can find new optimisation routes, cut expenses, anticipate deviations, improve their manufacturing systems, and gain access to insights and improved decision-making capabilities.

To guarantee compliant data capture, storage, and consumption, the system places a high priority on strict quality and compliance and adheres to GAMP5 for GMP procedures.

About Aizon

Aizon offers life sciences manufacturers the only GxP compliant SaaS solutions that let them aggregate and display their manufacturing process data, providing them with instant access to actionable insights and forecasts.